A bill to provide late-fee warnings to Medicare beneficiaries was introduced; Pfizer is expected to provide 10 million COVID-19 antiviral pills to low- and middle-income nations; a Texas judge halts an investigation into a 16-year-old girl receiving gender-affirming treatment.
As reported by CNBC, a bill was introduced in Congress aimed at preventing Medicare beneficiaries from facing late-enrollment penalties by warning them in advance. The measure, introduced in the Senate, has bipartisan support and would require the federal government to provide information about Medicare enrollment rules before reaching out to Medicare-eligible people aged 65 years. Although many beneficiaries are automatically enrolled into Medicare programs because they are already receiving Social Security benefits, this is not true for those who continue to work later in life and delay receiving benefits. Late-enrollment penalties are related to beneficiaries who sign up for Part B plans and equate to 10% of the standard Part B premium for every 12 months that a person should have been enrolled but was not. The penalties are life-lasting and can increase annually.
Pfizer is expected to ship 10 million courses of its COVID-19 antiviral pill Paxlovid to low- and middle-income nations during 2022, according to a report from Reuters. The news was announced by the Global Fund, a health care nongovernmental organization working to purchase the pills. The organization said Pfizer could increase shipments beyond the agreed amount later if organizations involved show they are able to distribute the pills effectively. Most of the courses are intended to be available by the end of the year. It’s not clear whether financial support will be available globally to buy the pills and to fund the infrastructure needed to distribute the pills to communities.
A Texas judge blocked Governor Abbott's call for the state to investigate parents of a 16-year-old transgender girl over gender-confirmation treatments, according to NPR. However, the judge did not prohibit the state from looking into reports about other children receiving similar care. The judge issued a temporary order halting the investigation. The governor’s order demanded the Department of Family and Protective Services to investigate the parents, teachers, and physicians allowing transgender children to receive gender-affirming care as child abuse. District Judge Amy Clark Meachum, who blocked the investigation, said that the teen in question risked infringement of their constitutional rights.
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
House lawmakers are expected to advance a contracting ban today on 5 Chinese research firms; US government officials temporarily relaxed strict guidelines on how laboratories handle, store, and transport H5N1 bird flu samples; a recent report found that the number of abortions occurring in the US continued to grow despite bans.
Read More